Deletion at 13q21 is associated with aggressive prostate cancers

Cancer Research

Volumn 60, Issue 14, 2000, Pages 3880-3883

  Dong, Jin Tang ^a   Chen, Ceshi ^a   Stultz, Brian G ^a   Isaacs, John T ^b   Frierson, Henry F ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN B RECEPTOR;

ADULT; AGED; ANIMAL CELL; ARTICLE; CHROMOSOME 13Q; CHROMOSOME DELETION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR DIFFERENTIATION;

AGED; AGED, 80 AND OVER; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 13; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; SEQUENCE TAGGED SITES; TUMOR CELLS, CULTURED;

EID: 0034660852     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Cancer statistics, 1999
2. Prostate cancer
3. Chromosomal clues to the development of prostate tumors
4. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
5. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts
6. Flow cytometric and karyotypic analysis of a primary small cell carcinoma of the prostate: A xenografted cell line
7. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer
8. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping
9. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization
10. Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization
11. Genetic alterations in hormone-refractory recurrent prostate carcinomas
12. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer
13. Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections
14. Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells
15. An STS-based map of the human genome
16. High-resolution YAC-cosmid-STS map of human chromosome 13
17. A physical map of 30,000 human genes
18. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease
19. Genomic organization of the human KAII metastasis-suppressor gene
20. Down-regulation of the KAII metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss
21. PTEN/MMACI is infrequently mutated in pT2 and pT3 carcinomas of the prostate
22. A high-resolution study of chromosome changes in a human prostatic carcinoma cell line (LNCaP)
23. The LNCaP cell line: A new model for studies on human prostatic carcinoma
24. Methylation of the 5′ CpG island of the endothelin B receptor gene is common in human prostate cancer
25. Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker
26. Loss of chromosome 13 is the most frequent genomic imbalance in malignant fibrous histiocytomas. A comparative genomic hybridization analysis of a series of 30 cases
27. Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization
28. Genetic imbalances in 67 synovial sarcomas evaluated by comparative genomic hybridization
29. Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization
30. Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization